IL81317A - 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them - Google Patents
1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL81317A IL81317A IL81317A IL8131787A IL81317A IL 81317 A IL81317 A IL 81317A IL 81317 A IL81317 A IL 81317A IL 8131787 A IL8131787 A IL 8131787A IL 81317 A IL81317 A IL 81317A
- Authority
- IL
- Israel
- Prior art keywords
- benzazecine
- chloro
- hexahydro
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
- C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D227/08—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH26686 | 1986-01-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL81317A0 IL81317A0 (en) | 1987-08-31 |
| IL81317A true IL81317A (en) | 1991-06-30 |
Family
ID=4183090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL81317A IL81317A (en) | 1986-01-23 | 1987-01-20 | 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US4732979A (da) |
| EP (1) | EP0230967B1 (da) |
| JP (1) | JPS62169770A (da) |
| KR (1) | KR910000659B1 (da) |
| CN (1) | CN1013111B (da) |
| AT (1) | ATE68790T1 (da) |
| AU (1) | AU590042B2 (da) |
| CS (1) | CS258147B2 (da) |
| DD (1) | DD264431A5 (da) |
| DE (1) | DE3773950D1 (da) |
| DK (1) | DK35887A (da) |
| FI (1) | FI82931C (da) |
| GB (1) | GB2185744B (da) |
| HU (1) | HU197883B (da) |
| IE (1) | IE870167L (da) |
| IL (1) | IL81317A (da) |
| IS (1) | IS3190A7 (da) |
| MC (1) | MC1795A1 (da) |
| MT (1) | MTP996B (da) |
| MW (1) | MW187A1 (da) |
| NO (1) | NO167385C (da) |
| NZ (1) | NZ218987A (da) |
| OA (1) | OA08469A (da) |
| PH (1) | PH22879A (da) |
| PL (1) | PL263796A1 (da) |
| PT (1) | PT84181B (da) |
| TN (1) | TNSN87006A1 (da) |
| YU (1) | YU7087A (da) |
| ZA (1) | ZA87407B (da) |
| ZW (1) | ZW1087A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU7087A (en) * | 1986-01-23 | 1988-06-30 | Hoffmann La Roche | Process for obtaining benzazecine derivatives |
| IN167395B (da) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
| ES2169026T3 (es) * | 1991-08-21 | 2002-07-01 | Lilly Co Eli | Benzo(f)quinolinonas como inhibidores de 5-alfa-reductasa. |
| US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
| ES2125884T3 (es) * | 1991-08-21 | 1999-03-16 | Lilly Co Eli | Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa. |
| US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
| WO1994022444A1 (en) * | 1993-03-29 | 1994-10-13 | Smithkline Beecham Corporation | Tricyclic compounds for inhibiting platelet aggregation |
| GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
| ATE190056T1 (de) * | 1994-09-20 | 2000-03-15 | Univ California | Brefeldin a und analoge zur verbesserung synaptischer übertragungen |
| US20050067341A1 (en) * | 2003-09-25 | 2005-03-31 | Green Dennis H. | Continuous production membrane water treatment plant and method for operating same |
| US7094331B2 (en) * | 2003-11-05 | 2006-08-22 | Marathon Ashland Petroleum Llc | Viscosity modification of heavy hydrocarbons using dihydric alcohols |
| US20090263439A1 (en) * | 2008-04-18 | 2009-10-22 | The Procter & Gamble Company | Antimicrobial Preservative Free Wipe |
| CN106117028B (zh) * | 2016-06-14 | 2019-01-01 | 浙江永太药业有限公司 | 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE442586A (da) * | 1940-07-31 | |||
| JPS5129710B2 (da) * | 1972-09-09 | 1976-08-27 | ||
| US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
| US4521423A (en) * | 1983-10-31 | 1985-06-04 | Ayerst, Mckenna & Harrison, Ltd. | 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them |
| YU7087A (en) * | 1986-01-23 | 1988-06-30 | Hoffmann La Roche | Process for obtaining benzazecine derivatives |
-
1987
- 1987-01-20 YU YU00070/87A patent/YU7087A/xx unknown
- 1987-01-20 DE DE8787100733T patent/DE3773950D1/de not_active Expired - Lifetime
- 1987-01-20 PH PH34744A patent/PH22879A/en unknown
- 1987-01-20 ZA ZA87407A patent/ZA87407B/xx unknown
- 1987-01-20 NZ NZ218987A patent/NZ218987A/en unknown
- 1987-01-20 CS CS87418A patent/CS258147B2/cs unknown
- 1987-01-20 MW MW1/87A patent/MW187A1/xx unknown
- 1987-01-20 EP EP87100733A patent/EP0230967B1/de not_active Expired - Lifetime
- 1987-01-20 IL IL81317A patent/IL81317A/xx unknown
- 1987-01-20 FI FI870220A patent/FI82931C/fi not_active IP Right Cessation
- 1987-01-20 AT AT87100733T patent/ATE68790T1/de not_active IP Right Cessation
- 1987-01-21 DD DD87299380A patent/DD264431A5/de unknown
- 1987-01-21 ZW ZW10/87A patent/ZW1087A1/xx unknown
- 1987-01-21 HU HU87163A patent/HU197883B/hu not_active IP Right Cessation
- 1987-01-21 US US07/005,712 patent/US4732979A/en not_active Expired - Fee Related
- 1987-01-22 MT MT996A patent/MTP996B/xx unknown
- 1987-01-22 MC MC871868A patent/MC1795A1/xx unknown
- 1987-01-22 IE IE870167A patent/IE870167L/xx unknown
- 1987-01-22 CN CN87100312A patent/CN1013111B/zh not_active Expired
- 1987-01-22 TN TNTNSN87006A patent/TNSN87006A1/fr unknown
- 1987-01-22 IS IS3190A patent/IS3190A7/is unknown
- 1987-01-22 DK DK035887A patent/DK35887A/da not_active Application Discontinuation
- 1987-01-22 AU AU67911/87A patent/AU590042B2/en not_active Ceased
- 1987-01-22 JP JP62011477A patent/JPS62169770A/ja active Pending
- 1987-01-22 NO NO870280A patent/NO167385C/no unknown
- 1987-01-22 GB GB8701416A patent/GB2185744B/en not_active Expired
- 1987-01-22 PT PT84181A patent/PT84181B/pt not_active IP Right Cessation
- 1987-01-23 KR KR1019870000533A patent/KR910000659B1/ko not_active IP Right Cessation
- 1987-01-23 PL PL1987263796A patent/PL263796A1/xx unknown
- 1987-01-23 OA OA59052A patent/OA08469A/xx unknown
- 1987-11-18 US US07/121,987 patent/US4749791A/en not_active Expired - Fee Related
-
1988
- 1988-02-11 US US07/154,760 patent/US4876340A/en not_active Expired - Fee Related
-
1989
- 1989-08-17 US US07/395,380 patent/US4957911A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL81317A (en) | 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them | |
| GB2126226B (en) | Pyridine derivatives | |
| NZ216172A (en) | Nucleosides and pharmaceutical compositions | |
| ES2010091A6 (es) | Un metodo para preparar compuestos analogos a nucleosidos didesoxicarbociclicos. | |
| ATE100098T1 (de) | Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen. | |
| IL87799A0 (en) | Saccharide derivatives,their preparation and pharmaceutical compositions containing them | |
| SE8304062L (sv) | Nya diklorerade derivat av 16alfa-metyl-pregnanserien, framstellning derav, anvendning derav som lekemedel och kompositioner innehallande dem | |
| NO911798D0 (no) | 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling. | |
| NZ224812A (en) | Derivatives of 2',3'-dideoxycytidine and pharmaceutical compositions | |
| OA09021A (fr) | Nouveaux dérivés de l'octahydro indeno-furane, leur préparation et compositions thérapeutiques en contenant. | |
| IL85508A (en) | 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them |